This seminal optogenetics methods paper introduces genetically encoded, blue-light–induced CRY2–CIB1 protein dimerization that (a) requires no exogenous chromophore, (b) activates within subsecond timescales and reverses over minutes, and (c) was validated for protein translocation, light-dose–dependent transcription and split-Cre recombination in cells — making a high-utility, broadly adoptable optogenetic dimerizer family (
Visual first: key claims and evidence (each claim linked to the source)
Kennedy et al. (2010) sits early in the wave of genetically encoded light-dimerizers. Compare/contrast with later single-component nuclear export (LEXY) and CRY2-based clustering tools:
The core strengths above depend on reproducible fast recruitment and chromophore independence; evidence that would materially alter the assessment:
Kennedy et al., 2010 delivered a practically useful, well-documented, and widely adopted two-component blue-light dimerizer (CRY2–CIB1) with fast on-kinetics, minute-scale reversibility, chromophore independence, and clear demonstrations of utility in recruitment, transcriptional control, and recombinase activation; limitations include overexpression dependence, minute-scale off-kinetics, and blue-light tissue penetration/phototoxicity concerns (
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.